Peter C. Kievit

Learn More
PURPOSE To assess current antithrombotic treatment strategies in the Netherlands in patients undergoing transcatheter aortic valve implantation (TAVI). METHODS For every Dutch hospital performing TAVI (n = 14) an interventional cardiologist experienced in performing TAVI was interviewed concerning heparin, aspirin, thienopyridine and oral anticoagulation(More)
since three have already been published. The information given was collected by the authors during the presentations and also from press releases prepared by some speakers. This report shows only preliminary results. During the first Hotline Session, studies on early and long-term treatment of acute coronary syndromes were presented. Dr Uwe Zeymer from(More)
OBJECTIVE We hypothesised that frailty assessment is of additional value to predict delirium and mortality after transcatheter aortic valve implantation (TAVI). METHODS Observational study in 89 consecutive patients who underwent TAVI. Inclusion from November 2012 to February 2014, follow-up until April 2014. Measurement of the association of variables(More)
BACKGROUND To evaluate the results of elective isolated surgical aortic valve replacement (SAVR) on quality of life (QoL) in patients > 75 years. METHODS 138 patients operated between January 2008 and December 2011 were included. The EuroQOL questionnaire (EQ-5D, EQ-VAS) was completed preoperatively, and 1- and 2-years postoperatively. The logistic(More)
A 83-year-old Caucasian male, known with chronic pulmonary disease, mild renal insufficiency, hypertension and epilepsy, was admitted to our tertiary referral centre for aortic valve replacement because of symptomatic severe aortic stenosis. Echocardiography showed aortic steno-sis with a peak gradient of 100 mmHg (aortic valve area 0.5 cm 2) and a(More)
  • 1